Legacy Wealth Partners (California)’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$461K Sell
5,923
-235
-4% -$17.5K 0.26% 68
2021
Q1
$453K Sell
6,158
-181
-3% -$13.4K 0.27% 64
2020
Q4
$495K Buy
6,339
+44
+0.7% +$3.37K 0.31% 58
2020
Q3
$498K Sell
6,295
-575
-8% -$45K 0.35% 58
2020
Q2
$507K Buy
6,870
+392
+6% +$29.5K 0.38% 57
2020
Q1
$476K Hold
6,478
0.44% 45
2019
Q4
$530K Buy
+6,478
New +$532K 0.39% 63

Other funds holding MRK

Legacy Wealth Partners (California)'s MRK Position: Q2 2021 in Review

Legacy Wealth Partners (California) reduced its Merck (MRK) stake by 3.8% in Q2 2021, selling an estimated $17.5K and leaving 5,923 shares worth $461K. The position accounts for 0.26% of the portfolio, ranked #68.

Legacy Wealth Partners (California) first reported a position in MRK in Q4 2019 and has held it in 7 quarters since. The position peaked at $530K in Q4 2019. 2,673 funds tracked by Wall St. Rank hold MRK as of Q2 2021.

  • Legacy Wealth Partners (California) held 5,923 shares of Merck worth $461K as of Q2 2021.
  • Legacy Wealth Partners (California) sold 235 Merck shares in Q2 2021, an estimated $17.5K.
  • Merck made up 0.26% of Legacy Wealth Partners (California)'s portfolio in Q2 2021, its #68 holding.
  • Legacy Wealth Partners (California) first reported a position in Merck in Q4 2019 and has held it in 7 quarters since.
  • Legacy Wealth Partners (California)'s Merck position peaked at $530K in Q4 2019.
  • 2,673 funds tracked by Wall St. Rank held Merck as of Q2 2021.

Based on Legacy Wealth Partners (California)'s 13F filing for Q2 2021, filed 16 Aug 2021.